Evidence map›Paper›PMID 33866463›Full record

ReviewInflammation2021

New Insights and Novel Therapeutic Potentials for Macrophages in Myocardial Infarction.

Zenglei Zhang, Junnan Tang, Xiaolin Cui, Bo Qin, Jianchao Zhang, Li Zhang, Hui Zhang, Gangqiong Liu, Wei Wang, Jinying Zhang

Open access · hybridAbstract readReview
In one paragraph

Review in Inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Research progress on macrophages in cardiovascular diseases.Journal of cardiothoracic surgery · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Zenglei Zhang *Department of Cardiology, First Affiliated Hospital of Zhengzhou University, NO. 1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, China.
Junnan Tang *Department of Cardiology, First Affiliated Hospital of Zhengzhou University, NO. 1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, China. fcctangjn@zzu.edu.cn.
Xiaolin CuiChristchurch Regenerative Medicine and Tissue Engineering (CReaTE) group, Department of Orthopaedic Surgery & Musculoskeletal Medicine, University of Otago, Christchurch, 8011, New Zealand.
Bo QinTranslational Medical Center, Zhengzhou University, Zhengzhou, Henan, China.
Jianchao ZhangDepartment of Cardiology, First Affiliated Hospital of Zhengzhou University, NO. 1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, China.
Li ZhangDepartment of Cardiology, First Affiliated Hospital of Zhengzhou University, NO. 1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, China.
Hui ZhangDepartment of Cardiology, First Affiliated Hospital of Zhengzhou University, NO. 1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, China.
Gangqiong LiuDepartment of Cardiology, First Affiliated Hospital of Zhengzhou University, NO. 1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, China.
Wei WangHenan Medical Association, Zhengzhou, Henan, China.
Jinying ZhangDepartment of Cardiology, First Affiliated Hospital of Zhengzhou University, NO. 1 Eastern Jianshe Road, Zhengzhou, 450052, Henan, China. jyzhang@zzu.edu.cn.
First Affiliated Hospital of Zhengzhou University · CNChinese Medical Association · CNUniversity of Otago · NZZhengzhou University · CN

Funding

Excellent Youth Science Foundation of Henan Province 202300410362Henan Medical Science and Technology Joint Building Program 2018020002Henan Province Youth Talent Promoting Project 2020HYTP051Henan Thousand Talents Program ZYQR201912131National Natural Science Foundation of China 81800267National Natural Science Foundation of China 81870328
6 · The paper itself

Abstract

Cardiovascular disease (CVD) has long been the leading cause of death worldwide, and myocardial infarction (MI) accounts for the greatest proportion of CVD. Recent research has revealed that inflammation plays a major role in the pathogenesis of CVD and other manifestations of atherosclerosis. Overwhelming evidence supports the view that macrophages, as the basic cell component of the innate immune system, play a pivotal role in atherosclerosis initiation and progression. Limited but indispensable resident macrophages have been detected in the healthy heart; however, the number of cardiac macrophages significantly increases during cardiac injury. In the early period of initial cardiac damage (e.g., MI), numerous classically activated macrophages (M1) originating from the bone marrow and spleen are rapidly recruited to damaged sites, where they are responsible for cardiac remodeling. After the inflammatory stage, the macrophages shift toward an alternatively activated phenotype (M2) that promotes cardiac repair. In addition, extensive studies have shown the therapeutic potential of macrophages as targets, especially for emerging nanoparticle-mediated drug delivery systems. In the present review, we focused on the role of macrophages in the development and progression of MI, factors regulating macrophage activation and function, and the therapeutic potential of macrophages in MI.

Indexed as

AnimalsAnti-Inflammatory AgentsCardiotonic AgentsHumansInflammation MediatorsMacrophage ActivationMacrophagesMyocardial InfarctionMyocardial Reperfusion InjuryMyocardiumAnti-Inflammatory AgentsCardiotonic AgentsInflammation Mediatorscardiac repairmacrophagesmyocardial infarctionpolarizationtherapeutic strategies

Identifiers

PMID33866463
PMCPMC8460536
OpenAlexW3154454711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.